Header Logo

Connection

Jerry Gurwitz to Drug-Related Side Effects and Adverse Reactions

This is a "connection" page, showing publications Jerry Gurwitz has written about Drug-Related Side Effects and Adverse Reactions.
  1. Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH. Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial. PLoS One. 2024; 19(2):e0297562.
    View in: PubMed
    Score: 0.790
  2. Rochon PA, Stall NM, Reppas-Rindlisbacher C, Gurwitz JH. STOPP/START version 3: even better with age. Eur Geriatr Med. 2023 08; 14(4):635-637.
    View in: PubMed
    Score: 0.761
  3. Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017 05 06; 389(10081):1778-1780.
    View in: PubMed
    Score: 0.494
  4. Kanaan AO, Donovan JL, Duchin NP, Field TS, Tjia J, Cutrona SL, Gagne SJ, Garber L, Preusse P, Harrold LR, Gurwitz JH. Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications. J Am Geriatr Soc. 2013 Nov; 61(11):1894-9.
    View in: PubMed
    Score: 0.385
  5. Gurwitz JH. The physics of geriatric pharmacotherapy: overcoming therapeutic inertia and momentum. Am J Med. 2012 Jun; 125(6):523-4.
    View in: PubMed
    Score: 0.348
  6. Field TS, Tjia J, Mazor KM, Donovan JL, Kanaan AO, Harrold LR, Reed G, Doherty P, Spenard A, Gurwitz JH. Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach. Am J Med. 2011 Feb; 124(2):179.e1-7.
    View in: PubMed
    Score: 0.320
  7. Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc. 2007 Feb; 55(2):271-6.
    View in: PubMed
    Score: 0.243
  8. Mazor KM, Andrade SE, Auger J, Fish L, Gurwitz JH. Communicating safety information to physicians: an examination of dear doctor letters. Pharmacoepidemiol Drug Saf. 2005 Dec; 14(12):869-75.
    View in: PubMed
    Score: 0.224
  9. Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005 Dec; 43(12):1171-6.
    View in: PubMed
    Score: 0.224
  10. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Auger J, Bates DW. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med. 2005 Mar; 118(3):251-8.
    View in: PubMed
    Score: 0.212
  11. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 05; 289(9):1107-16.
    View in: PubMed
    Score: 0.185
  12. McCarthy LM, Savage R, Dalton K, Mason R, Li J, Lawson A, Wu W, Sternberg SA, Byrne S, Petrovic M, Onder G, Cherubini A, O'Mahony D, Gurwitz JH, Pegreffi F, Rochon PA. ThinkCascades: A Tool for Identifying Clinically Important Prescribing Cascades Affecting Older People. Drugs Aging. 2022 10; 39(10):829-840.
    View in: PubMed
    Score: 0.179
  13. Sternberg SA, Petrovic M, Onder G, Cherubini A, O'Mahony D, Gurwitz JH, Pegreffi F, Mason R, Akerman J, McCarthy L, Lawson A, Li J, Wu W, Rochon PA. Identifying key prescribing cascades in older people (iKASCADE): a transnational initiative on drug safety through a sex and gender lens-rationale and design. Eur Geriatr Med. 2021 06; 12(3):475-483.
    View in: PubMed
    Score: 0.162
  14. Brath H, Mehta N, Savage RD, Gill SS, Wu W, Bronskill SE, Zhu L, Gurwitz JH, Rochon PA. What Is Known About Preventing, Detecting, and Reversing Prescribing Cascades: A Scoping Review. J Am Geriatr Soc. 2018 11; 66(11):2079-2085.
    View in: PubMed
    Score: 0.137
  15. Rochon PA, Gruneir A, Gill SS, Wu W, Zhu L, Herrmann N, Bell CM, Austin PC, Stall NM, McCarthy L, Giannakeas V, Alberga A, Seitz DP, Normand SL, Gurwitz JH, Bronskill SE. Initial Cholinesterase Inhibitor Therapy Dose and Serious Events in Older Women and Men. J Am Geriatr Soc. 2018 09; 66(9):1692-1699.
    View in: PubMed
    Score: 0.134
  16. Wenger NK, Doherty CL, Gurwitz JH, Hirsch GA, Holmes HM, Maurer MS, Murray MD. Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease. Drugs Aging. 2017 11; 34(11):803-810.
    View in: PubMed
    Score: 0.128
  17. Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):226-34.
    View in: PubMed
    Score: 0.070
  18. Rochon PA, Field TS, Bates DW, Lee M, Gavendo L, Erramuspe-Mainard J, Judge J, Gurwitz JH. Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc. 2005 Oct; 53(10):1780-9.
    View in: PubMed
    Score: 0.055
  19. Field TS, Gurwitz JH, Harrold LR, Rothschild JM, Debellis K, Seger AC, Fish LS, Garber L, Kelleher M, Bates DW. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):492-8.
    View in: PubMed
    Score: 0.051
  20. Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC, Auger JC, Garber LA, Cadoret C, Fish LS, Garber LD, Kelleher M, Bates DW. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004 Aug; 52(8):1349-54.
    View in: PubMed
    Score: 0.051
  21. Allen LaPointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, Gurwitz JH, Raebel MA, Platt R. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):361-8.
    View in: PubMed
    Score: 0.014
  22. Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):369-86.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.